Successful unrelated cord blood transplantation for Epstein-Barr virus-associated lymphoproliferative disease with hemophagocytic syndrome

International Journal of Hematology

Volumn 80, Issue 5, 2004, Pages 458-462

  Toubo, Taikai ^a   Suga, Naohiro ^a   Ohga, Shouichi ^a,b   Nomura, Akihiko ^a   Onoe, Yasuhiro ^a   Takada, Hidetoshi ^a   Hara, Toshiro ^a  

^a KYUSHU UNIVERSITY   (Japan)

^b KYUSHU UNIVERSITY   (Japan)

Author keywords

Cord blood transplantation; Epstein Barr virus; Hemophagocytic syndrome; Hepatosplenic lymphoma; Lymphoproliferative disease

Indexed keywords

BUSULFAN; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; CYTARABINE; DOXORUBICIN; ETOPOSIDE; HLA A1 ANTIGEN; METHOTREXATE; METHYLPREDNISOLONE; PIRARUBICIN; VINCRISTINE SULFATE; VIRUS DNA;

ABDOMINAL PAIN; ACUTE DISEASE; ARTICLE; CASE REPORT; CHILD; CHIMERA; CORD BLOOD STEM CELL TRANSPLANTATION; DISEASE COURSE; EPSTEIN BARR VIRUS; FEMALE; FEVER; GENE LOCUS; GRAFT VERSUS HOST REACTION; HEMOPHAGOCYTIC SYNDROME; HEPATOSPLENOMEGALY; HISTOPATHOLOGY; HLA MATCHING; HUMAN; LYMPHOMA; LYMPHOPROLIFERATIVE DISEASE; SIDE EFFECT; SKIN DISEASE; STEM CELL; TREATMENT OUTCOME;

CHILD; CORD BLOOD STEM CELL TRANSPLANTATION; EPSTEIN-BARR VIRUS INFECTIONS; FEMALE; HERPESVIRUS 4, HUMAN; HISTIOCYTOSIS, NON-LANGERHANS-CELL; HISTOCOMPATIBILITY; HUMANS; LYMPHOPROLIFERATIVE DISORDERS; TRANSPLANTATION CHIMERA; TRANSPLANTATION CONDITIONING;

EID: 11144234818     PISSN: 09255710     EISSN: None     Source Type: Journal    
DOI: 10.1532/IJH97.04081     Document Type: Article

References (29)

1. Arico M, Danesino C, Pende D, Moretta L. Pathogenesis of haemophagocytic lymphohistiocytosis. Br J Haematol. 2001;114: 761-769.
2. Janka GE, Schneider EM. Modern management of children with haemophagocytic lymphohistiocytosis. Br J Haematol. 2004;124:4-14.
3. Ohga S, Nomura A, Takada H, Hara T. Immunological aspects of Epstein-Barr virus infection. Crit Rev Oncol Hematol. 2002;44: 203-215.
4. Grom AA. Macrophage activation syndrome and reactive hemophagocytic lymphohistiocytosis: the same entities? Curr Opin Rheumatol. 2003;15:587-590.
5. Suga N, Takada H, Komura A, et al. Perforin defects of primary haemophagocytic lymphohistiocytosis in Japan. Br J Haematol. 2002;116:346-349.
6. Feldmann J, Callebaut I, Raposo G, et al. Munc13-4 is essential for cytolytic granules fusion and is mutated in a form of familial hemophagocytic lymphohistiocytosis (FHL3). Cell. 2003;115:461-473.
7. Barker JN, Martin PL, Coad JE, et al. Low incidence of Epstein-Barr virus-associated posttransplantation lymphoproliferative disorders in 272 unrelated-donor umbilical cord blood transplant recipients. Biol Blood Marrow Transplant. 2001;7:395-399.
8. Ohga S, Kanaya Y, Maki H, et al. Epstein-Barr virus-associated lymphoproliferative disease after a cord blood transplant for Diamond-Blackfan anemia. Bone Marrow Transplant. 2000;25: 209-212.
9. Haut PR, Kovarik P, Shaw PH, Walterhouse D, Jenson HB, Kletzel M. Detection of EBV DNA in the cord blood donor for a patient developing Epstein-Barr virus-associated lymphoproliferative disorder following mismatched unrelated umbilical cord blood transplantation. Bone Marrow Transplant. 2001;27:761-765.
10. Imashuku S. Clinical features and treatment strategies of Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis. Crit Rev Oncol Hematol. 2002;44:259-272.
11. Arico M, Allen M, Brusa S, et al. Haemophagocytic lymphohistiocytosis: proposal of a diagnostic algorithm based on perform expression. Br J Haematol. 2002;119:180-188.
12. Ohga S, Kimura N, Takada H, et al. Restricted diversification of T-cells in chronic active Epstein-Barr virus infection: potential inclination to T-lymphoproliferative disease. Am J Hematol. 1999; 61:26-33.
13. Lechowicz MJ, Lin L, Ambinder RF. Epstein-Barr virus DNA in body fluids. Curr Opin Oncol. 2002;14:533-537.
14. Belhadj K, Reyes F, Parcel JP, et al. Hepatosplenic γδ T-cell lymphoma is a rare clinicopathologic entity with poor outcome: report on a series of 21 patients. Blood. 2003;102:4261-4269.
15. Ohshima K, Haraoka S, Harada N, et al. Hepatosplenic γδ T-cell lymphoma: relation to Epstein-Barr virus and activated cytotoxic molecules. Histopathology. 2000;36:127-135.
16. Shibuya A, Tsuchihashi T, Watanabe M, et al. Severe chronic active Epstein-Barr virus infection associated with multiple necrotic lesions in the liver. Hepatol Res. 2003;25:447-454.
17. Kawa K, Okamura T, Yasui M, Sato E, Inoue M. Allogeneic hematopoietic stem cell transplantation for Epstein-Barr virus-associated T/NK-cell lymphoproliferative disease. Crit Rev Oncol Hematol. 2002;44:251-257.
18. Taketani T, Kikuchi A, Inatomi J, et al. Chronic active Epstein-Barr virus infection (CAEBV) successfully treated with allogeneic peripheral blood stem cell transplantation. Bone Marrow Transplant. 2002;29:531-533.
19. Okamura T, Kishimoto T, Inoue M, et al. Unrelated bone marrow transplantation for Epstein-Barr virus-associated T/NK-cell lymphoproliferative disease. Bone Marrow Transplant. 2003;31: 105-111.
20. Minegishi M, Ohashi Y, Kumaki S, et al. Successful umbilical cord blood transplantation from an unrelated donor for a patient with Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis. Bone Marrow Transplant. 2001;27:883-886.
21. Yagi T, Fujino H, Hirai M, et al. Esophageal actinomycosis after allogeneic peripheral blood stem cell transplantation for extranodal natural killer/T cell lymphoma, nasal type. Bone Marrow Transplant. 2003;32:451-453.
22. Heslop HE, Ng CY, Li C, et al. Long-term restoration of immunity against Epstein-Barr virus infection by adoptive transfer of gene-modified virus-specific T lymphocytes. Nat Med. 1996;2:551-555.
23. Kuzushima K, Yamamoto M, Kimura H, et al. Establishment of anti-Epstein-Barr virus (EBV) cellular immunity by adoptive transfer of virus-specific cytotoxic T lymphocytes from an HLA-matched sibling to a patient with severe chronic active EBV infection. Clin Exp Immunol. 1996;103:192-198.
24. Imashuku S, Hibi S, Todo S, et al. Allogeneic hematopoietic stem cell transplantation for patients with hemophagocytic syndrome (HPS) in Japan. Bone Marrow Transplant. 1999;23:569-572.
25. Weinthal JA, Goldman SC, Lenarsky C. Successful treatment of relapsed Burkitt's lymphoma using unrelated cord blood transplantation as consolidation therapy. Bone Marrow Transplant. 2000;25:1311-1313.
26. + T cells and NK cells inhibit Epstein-Barr virus B-cell transformation in vitro. J Virol. 2002;76:5071-5081.
27. Moretta A, Comoli P, Montagna D, et al. High frequency of Epstein-Barr virus (EBV) lymphoblastoid cell line-reactive lymphocytes in cord blood: evaluation of cytolytic activity and IL-2 production. Clin Exp Immunol. 1997;107:312-320.
28. + Epstein-Barr virus-specific cytotoxic T-lymphocytes from human umbilical cord blood. Cell Immunol. 1999;195:81-88.
29. Marshall NA, Howe JG, Formica R, et al. Rapid reconstitution of Epstein-Barr virus-specific T lymphocytes following allogeneic stem cell transplantation. Blood. 2000;96:2814-2821.